Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
Hand-out
Press Releases
January 22, 2025

Samsung Biologics reports fourth quarter and fiscal year 2024 financial results

Recorded Q4'24 consolidated revenue of KRW 1.26 trillionRecorded FY'24 consolidated revenue of KRW 4.55 trillionPoised for further growth with expanded capacity and new service offerings

bradford

The Bradford Era

Local & Social